In the present study, we applied NGS, Sanger sequencing, and MLPA to screen germline SNV/indel and CNVs in BRCA1/2 among 100 BC patients enrolled at the only tertiary cancer‐specialized public hospital located in business capital, Dar es Salaam, Tanzania. This evidence concerns the gene BRCA1 and cancer.